Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Cantor Fitzgerald
Johnson and Johnson
Citi
Accenture
Medtronic

Generated: September 19, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for OTO-104

  Try a free trial


See Plans and Pricing

« Back to Dashboard

US Patents for OTO-104

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
OTO-104 ➤ Sign Up 11-substituted bile acid derivatives, process for the preparation thereof and use of these compounds as medicaments Council of Scientific and Industrial Research (New Delhi, IN) ➤ Sign Up
OTO-104 ➤ Sign Up Low, immune enhancing, dose mtor inhibitors and uses thereof Novartis AG (Basel, CH) ➤ Sign Up
OTO-104 ➤ Sign Up Therapeutic compounds and methods of use thereof GENENTECH, INC. (South San Francisco, CA) XENON PHARMACEUTICALS INC. (Burnaby, BC, CA) ➤ Sign Up
OTO-104 ➤ Sign Up Substituted indole Mcl-1 inhibitors Vanderbilt University (Nashville, TN) ➤ Sign Up
OTO-104 ➤ Sign Up Pharmaceutical compounds Cascadian Therapeutics, Inc. (Seattle, WA) ➤ Sign Up
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Subscribe to access the full database, or try a Free Trial

International Patents for OTO-104

Drugname Country Document Number Estimated Expiration Related US Patent
OTO-104 World Intellectual Property Organization (WIPO) 2015087340 1989-12-31 ➤ Sign Up
OTO-104 Australia 2014348657 2033-11-13 ➤ Sign Up
OTO-104 Australia 2017245411 2033-11-13 ➤ Sign Up
OTO-104 Canada 2929181 2033-11-13 ➤ Sign Up
OTO-104 China 105899232 2033-11-13 ➤ Sign Up
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
McKinsey
Harvard Business School
UBS
Express Scripts
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.